Connect with us


Surna Inc (OTCMKTS:SRNA) Continues to Trade Below $0.09 Mark



Surna Inc

Surna Inc (OTCMKTS:SRNA) has been trading below the $0.09 per share mark, after a spike on April 24, 2016, which was short lived. The majority of the hype around the stock was the result of more states legalizing marijuana. Since, SRNA does not produce or sell marijuana itself, its progress is closely linked with the growth of the industry as a whole. Surna Inc. is the provider of technologies, used in the monitoring and control of indoor marijuana cultivation.

Unfortunately, much like many other cannabis companies, SRNA is not profitable as yet. However, the FY2015 results, filed last month, revealed strong growth. During the conference call, SRNA CEO, Stephen Keen, had revealed that the company would be focusing on the commercialization of its technologies, during FY2016. He also recalled that the company has installed a new management team, in a bid to become profitable.

For the FY2015, SRNA recorded a revenue growth of 328%, which was a result of focusing efforts in all aspects of the business. The increased efforts also led to a $0.6 million increase in operating expenses. However, operating expenses as a percentage of revenue declined, from 190% to 52%, reflecting on SRNA becoming more efficient. The net loss for the year stood at $0.04 per share, compared to $0.03 in FY2014. Moreover, majority of the operating expenses were used in marketing of company products and attracting media attention.

A recent form 8-K further reaffirmed the management’s commitment to the progress of the company. The filing revealed that two SRNA executives, Stephen and Brandy Keen, had agreed to postpone the deadline for the payment of their promissory notes. Furthermore, the amendment also allowed the company to pay the Keens in installments. As such, SRNA has sufficient capital at its disposal, for possible expansion.

Surna Inc (OTCMKTS:SRNA) did not report a change in its share value, despite having a trade volume of 703,515, to close at $0.008 per share, at the end of May 9.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.


Business2 days ago

CytoDyn Inc (OTCMKTS: CYDY) Announces Study to Investigate Leronlimab for Triple-negative Breast Cancer Treatment

Post Views: 18 CytoDyn Inc (OTCMKTS: CYDY) has announced that there will be a study on the drug leronlimab and...

Business2 days ago

Curaleaf Holdings Inc (OTCMKTS: CURLF) Completes Acquisition of Los Sueños Farms

Post Views: 38 Curaleaf Holdings Inc (OTCMKTS: CURLF) has completed the acquisition of the most enormous outdoor grow in Colorado,...

Business2 days ago

BAE SYSTEMS ADR (OTCMKTS: BAESY) and Keep Scotland Beautiful Launch Cleaning Hub in Govan

Post Views: 14 BAE SYSTEMS ADR (OTCMKTS: BAESY), a designer, developer and manufacturer of aerospace systems used in space, land,...

Business2 days ago

Charlotte’s Web Holdings Inc (OTCMKTS: CWBHF) Announces it Will Expand Distribution Following Passing of Assembly Bill 45

Post Views: 10 Charlotte’s Web Holdings Inc (OTCMKTS: CWBHF) has announced that it will expand product distribution in California following...

Technology3 days ago

BAE Systems Inc. (OTCMKTS: BAESY) Granted five-year $68.5 Million Air Traffic Control Contract

Post Views: 12 BAE Systems Inc. (OTCMKTS: BAESY) has been picked for a 5-year $68.5M indefinite-quantity, indefinite-delivery contract enabling it...

Business3 days ago

CytoDyn Inc (OTCMKTS: CYDY) Announces Appointments of New Chief Operating Officer and Senior Executive Vice President

Post Views: 30 CytoDyn Inc (OTCMKTS: CYDY) has announced that it has appointed Nitya Ray, Ph.D., to act as its...